Elicit Plant has raised €45 million in equity financing to enhance its global expansion and support sustainable agriculture through innovative biosolutions.

Target Information

Elicit Plant, a leading agri-biotech company, has successfully secured €45 million in new equity financing to bolster its global expansion efforts. With a focus on delivering innovative bio-based solutions, Elicit Plant aims to tackle the pressing climate challenges that threaten agricultural yields and the ability to sustain food supplies worldwide. The recent investment will primarily aid in the commercialization of existing offerings and support the development of new biosolutions targeted at enhancing agricultural productivity.

Since its inception, Elicit Plant has established itself as a key player within the agri-biotech sector, particularly recognized for its EliTerra® technology that utilizes phytosterols to reduce plant stress and improve resilience. The company has carved a significant niche in markets across France, Brazil, and Eastern Europe, with a particular emphasis on crops such as corn, sunflowers, cereals, and soy.

Industry Overview

The global agri-biotech industry is currently evolving in response to the increasing threats posed by climate change. Farmers are faced with unpredictable weather patterns and frequent extremes, making the development of